Compare · ILMN vs KEQU
ILMN vs KEQU
Side-by-side comparison of Illumina Inc. (ILMN) and Kewaunee Scientific Corporation (KEQU): market cap, price performance, sector, and recent activity on the wire.
Summary
- ILMN operates in Health Care, while KEQU operates in Industrials - the two are in different parts of the market.
- ILMN is the larger of the two at $40.46B, about 434.1x KEQU ($93.2M).
- Over the past year, ILMN is up 164.0% and KEQU is down 24.2% - ILMN leads by 188.2 points.
- ILMN has hit the wire 8 times in the past 4 weeks while KEQU has been quiet.
- ILMN has more recent analyst coverage (25 ratings vs 0 for KEQU).
- Company
- Illumina Inc.
- Kewaunee Scientific Corporation
- Price
- $262.52-2.06%
- $32.40-9.75%
- Market cap
- $40.46B
- $93.2M
- 1M return
- +7.01%
- -9.75%
- 1Y return
- +164.02%
- -24.21%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2000
- News (4w)
- 8
- 0
- Recent ratings
- 25
- 0
Illumina Inc.
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has a collaboration agreement with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer. The company was incorporated in 1998 and is headquartered in San Diego, California.
Kewaunee Scientific Corporation
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. It operates in two segments, Domestic and International. The company's products include steel, wood, laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services. Its laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture; and laminate caseworks that are used in educational, healthcare, and industrial applications. The company sells its products primarily through dealers, commissioned agents, and a national distributor, as well as through competitive bids submitted by the company and its subsidiaries in Singapore, India, and China. Kewaunee Scientific Corporation was founded in 1906 and is headquartered in Statesville, North Carolina.
Latest ILMN
- Illumina launches BioInsight Platform, its first unified software environment to help accelerate genomic and multiomic breakthroughs
- SEC Form 8-K filed by Illumina Inc.
- Illumina to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026
- Illumina releases SpliceAI2 to help advance rare disease research
- SEC Form 4 filed by Illumina Inc.
- SEC Form SCHEDULE 13G filed by Illumina Inc.
- Director Meister Keith A. was granted 107 shares, increasing direct ownership by 2% to 6,887 units (SEC Form 4)
- Director Ullem Scott B. was granted 113 shares, increasing direct ownership by 1% to 11,143 units (SEC Form 4)
- Chief Legal Officer Coletti Julie Ann was granted 18,763 shares (SEC Form 4)
- SVP, Chief Technology Officer Barnard Steven covered exercise/tax liability with 408 shares, decreasing direct ownership by 0.99% to 40,927 units (SEC Form 4)
Latest KEQU
- SEC Form 10-Q filed by Kewaunee Scientific Corporation
- Kewaunee Scientific Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2027
- Kewaunee Scientific Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Kewaunee Scientific Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Kewaunee Scientific Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2027
- SEC Form DEFA14A filed by Kewaunee Scientific Corporation
- SEC Form DEF 14A filed by Kewaunee Scientific Corporation
- SVP, People & Culture Phillips Elizabeth D converted options into 6,656 shares, returned $181,069 worth of shares to the company (4,995 units at $36.25) and covered exercise/tax liability with 793 shares, increasing direct ownership by 11% to 9,116 units (SEC Form 4)